IVAN ROSAS to Risk Assessment
This is a "connection" page, showing publications IVAN ROSAS has written about Risk Assessment.
Connection Strength
0.134
-
Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med. 2012 Jun 01; 185(11):1147-53.
Score: 0.042
-
Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis. Chest. 2011 Dec; 140(6):1590-1597.
Score: 0.040
-
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017 11; 5(11):857-868.
Score: 0.015
-
The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death. Transplantation. 2017 09; 101(9):2207-2212.
Score: 0.015
-
Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study. Eur Respir J. 2015 Sep; 46(3):783-94.
Score: 0.013
-
Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2010 Jan; 17(1):48-53.
Score: 0.009